PW MEDTECH (01358) announced on May 13th that it spent 359,900 Hong Kong dollars to repurchase 305,000 shares.
Puhua Group (01358) issued an announcement on May 13, 2026, stating the repurchase of 305,000 shares at a cost of 359,900 Hong Kong dollars.
PW MEDTECH (01358) announced on May 13, 2026 that it will spend HK$359,000 to repurchase 305,000 shares.
Related Articles
RONGZUN INT'L (01780) appoints Winbo Capital as independent financial advisor.
CH INNOVATION (01217) reported a net asset value per share of approximately 0.045 Hong Kong dollars at the end of April.
EAST BUY (01797) spent 18.757 million Hong Kong dollars to repurchase 719,500 shares on May 13th.
RONGZUN INT'L (01780) appoints Winbo Capital as independent financial advisor.
CH INNOVATION (01217) reported a net asset value per share of approximately 0.045 Hong Kong dollars at the end of April.
EAST BUY (01797) spent 18.757 million Hong Kong dollars to repurchase 719,500 shares on May 13th.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
